Decision Making by p53: Life versus Death

Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, New York.
Molecular and Cellular Pharmacology 01/2010; 2(2):69-77. DOI: 10.4255/mcpharmacol.10.10
Source: PubMed


Cellular response to DNA damage is multifacted in nature and involves a complex signaling network in which p53 functions as a "molecular node" for converging signals. p53 has been implicated in a variety of cellular processes primarily functioning as a transcription factor and also in a transcription-independent manner. It is rapidly activated following DNA damage with phosphorylation as one of the initial signals. Cellular context as well as the type and severity of DNA damage determine p53 activation code, and its activities are regulated predominantly through protein degradation, post-translational modification and interactions with various cellular co-factors. These events are crucial in decision making by p53 as it has the ability to receive, assess and integrate different signals and route them accordingly to induce cell death or promote cell survival. In this decision making process, its transcriptional role to activate a specific subset of target genes linked to inducing cell cycle arrest or apoptosis is critical that is further fine-tuned by its transcription-independent function. This article reviews the current state of knowledge about the role of p53 in determining the fate of cells that have incurred DNA damage.

Download full-text


Available from: Lingyan Jiang, Dec 19, 2013
  • Source
    • "This was achieved by selection of a cell line with reduced metabolic activity and reduction of the incubation time to 4 h (Pieterse et al. 2013). The p53 CALUX is a reporter assay that quantifies activity mediated by the p53 protein which is the major regulator for cellular responses towards genotoxicity such as cell cycle arrest, activation of DNA repair mechanisms, and initiation of apoptosis (van der Linden et al. 2014; Jiang et al. 2010). Since various compounds may only elicit genotoxic effects after metabolic activation (for which the U2OS cell line has very limited capability; Geiger et al. 2012; Beck et al. 2013), the p53 CALUX may be complemented with an in vitro metabolizing system such as microsomal S9 fractions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A combined chemical and biological analysis of samples from a major obsolete pesticide and persistent organic pollutant (POP) dumpsite in Northern Tajikistan was carried out. The chemical analytical screening focused on a range of prioritized compounds and compounds known to be present locally. Since chemical analytics does not allow measurements of hazards in complex mixtures, we tested the use of a novel effect-based approach using a panel of quantitative high-throughput CALUX reporter assays measuring distinct biological effects relevant in hazard assessment. Assays were included for assessing effects related to estrogen, androgen, and progestin signaling, aryl hydrocarbon receptor-mediated signaling, AP1 signaling, genotoxicity, oxidative stress, chemical hypoxia, and ER stress. With this panel of assays, we first quantified the biological activities of the individual chemicals measured in chemical analytics. Next, we calculated the expected sum activity by these chemicals in the samples of the pesticide dump site and compared the results with the measured CALUX bioactivity of the total extracts of these samples. The results showed that particularly endocrine disruption-related effects were common among the samples. This was consistent with the toxicological profiles of the individual chemicals that dominated these samples. However, large discrepancies between chemical and biological analysis were found in a sample from a burn place present in this site, with biological activities that could not be explained by chemical analysis. This is likely to be caused by toxic combustion products or by spills of compounds that were not targeted in the chemical analysis.
    Full-text · Article · May 2015 · Environmental Science and Pollution Research
  • Source
    • "ROS-mediated DNA damage in mouse skin leads to enhanced expression of p53 and p21waf1 that causes cell cycle arrest at the G0/G1 and G2/M phases12 as reported by Abbas and Dutta in in vitro models69, to enhanced Bax/Bcl2 ratio and cytochrome c release, and to activated caspase 9 and 3 but not caspase 8, which result in apoptosis through the mitochondria-mediated pathway12. The p53 protein plays a key role in the DNA damage response pathway by transmitting a variety of stress signals associated with antiproliferative cellular responses that lead to apoptosis70, and the lack of enhancement in caspase 8 activity indicates that the extrinsic or death receptor pathway of apoptosis is not activated by CTN in mouse skin. Moreover, Kumar et al. clarified that topical treatment of bio-antioxidants such as butylated hydroxyanisole, quercetin and α-tocopherol abolishes CTN-induced oxidative stress, cell cycle arrest and apoptosis, confirming the direct involvement of ROS in CTN-induced toxicological manifestations in mouse skin12. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Among the many mycotoxins, T-2 toxin, citrinin (CTN), patulin (PAT), aflatoxin B1 (AFB1) and ochratoxin A (OTA) are known to have the potential to induce dermal toxicity and/or tumorigenesis in rodent models. T-2 toxin, CTN, PAT and OTA induce apoptosis in mouse or rat skin. PAT, AFB1 and OTA have tumor initiating properties, and OTA is also a tumor promoter in mouse skin. This paper reviews the molecular mechanisms of dermal toxicity and tumorigenesis induced in rodent models by these mycotoxins especially from the viewpoint of oxidative stress-mediated pathways.
    Full-text · Article · Apr 2014 · Journal of Toxicologic Pathology
  • Source
    • "The tumor suppressor p53 is a transcriptional activator that plays an essential role in DNA damage response by inducing cell cycle arrest, senescence and/or apoptosis [35], [36]. p53 triggers cell cycle arrest at G1 phase by transactivating cyclin-dependent kinase inhibitor 1A (CDKN1A)/p21 gene which causes cell cycle arrest and suppresses cell proliferation [37], [38], [39]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The human AP-endonuclease (APE1/Ref-1), an essential multifunctional protein involved in repair of oxidative DNA damage as well as in transcriptional regulation, is often overexpressed in tumor cells. APE1 was earlier shown to stimulate p53's DNA binding and its transactivation function in the expression of cyclin-dependent kinase inhibitor p21 (CDKN1A) gene. Here, we show APE1's stable binding to p53 cis elements which are required for p53-mediated activation of p21 in p53-expressing wild type HCT116 cells. However, surprisingly, we observed APE1-dependent repression of p21 in isogenic p53-null HCT116 cells. Ectopic expression of p53 in the p53-null cells abrogated this repression suggesting that APE1's negative regulatory role in p21 expression is dependent on the p53 status. We then identified APE1's another binding site in p21's proximal promoter region containing cis elements for AP4, a repressor of p21. Interestingly, APE1 and AP4 showed mutual dependence for p21 repression. Moreover, ectopic p53 in p53-null cells inhibited AP4's association with APE1, their binding to the promoter and p21 repression. These results together establish APE1's role as a co-activator or co-repressor of p21 gene, dependent on p53 status. It is thus likely that APE1 overexpression and inactivation of p53, often observed in tumor cells, promote tumor cell proliferation by constitutively downregulating p21 expression.
    Full-text · Article · Jul 2013 · PLoS ONE
Show more